热门资讯> 正文
ASlan Pharmaceuticals宣布计划实施ADS比率变更
2024-06-15 05:00
- ASLAN Pharmaceuticals (NASDAQ:ASLN) on Friday said it plans to change the ratio of the American Depositary Shares to its ordinary shares, par value $0.01 per share, from one ADS representing twenty-five ordinary shares to one ADS representing two hundred ordinary shares.
- The ADSs will continue to be traded on Nasdaq under the symbol “ASLN”.
- ASLN +1.05% after hours to $0.41.
- Source: Press Release
More on ASLAN Pharmaceuticals
- ASLAN Pharmaceuticals announces receipt of Nasdaq notice
- Seeking Alpha’s Quant Rating on ASLAN Pharmaceuticals
- Historical earnings data for ASLAN Pharmaceuticals
- Financial information for ASLAN Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
